Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial.

Delforge M, Devos T, Rowe J, Español I, Durrant ST, Raddoux J, Boogaerts M, Gramatzki M, Gunther A.

Leuk Lymphoma. 2016 Feb;57(2):470-473. doi: 10.3109/10428194.2015.1055481. Epub 2015 Jul 7. No abstract available.

PMID:
26022523
2.
3.

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.

van Kampen RJ, Canals C, Schouten HC, Nagler A, Thomson KJ, Vernant JP, Buzyn A, Boogaerts MA, Luan JJ, Maury S, Milpied NJ, Jouet JP, Ossenkoppele GJ, Sureda A.

J Clin Oncol. 2011 Apr 1;29(10):1342-8. doi: 10.1200/JCO.2010.30.2596. Epub 2011 Feb 14.

PMID:
21321299
4.

The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma.

Delgado J, Canals C, Attal M, Thomson K, Campos A, Martino R, Littlewood T, Jackson G, Milpied N, Boogaerts M, Hunter A, Janssen JJ, Montoto S, Sureda A; EBMT.

Leukemia. 2011 Mar;25(3):551-5. doi: 10.1038/leu.2010.292. Epub 2010 Dec 24. No abstract available.

PMID:
21183951
5.

The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry.

Michallet M, Sobh M, Milligan D, Morisset S, Niederwieser D, Koza V, Ruutu T, Russell NH, Verdonck L, Dhedin N, Vitek A, Boogaerts M, Vindelov L, Finke J, Dubois V, van Biezen A, Brand R, de Witte T, Dreger P; Chronic Leukemia Working Party of the EBMT.

Leukemia. 2010 Oct;24(10):1725-31. doi: 10.1038/leu.2010.165. Epub 2010 Aug 12.

PMID:
20703257
6.

Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.

Janssens A, Boogaerts M, Verhoef G.

Drug Des Devel Ther. 2009 Dec 29;3:241-52.

7.

Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia.

Lim Z, Brand R, Martino R, van Biezen A, Finke J, Bacigalupo A, Beelen D, Devergie A, Alessandrino E, Willemze R, Ruutu T, Boogaerts M, Falda M, Jouet JP, Niederwieser D, Kroger N, Mufti GJ, De Witte TM.

J Clin Oncol. 2010 Jan 20;28(3):405-11. doi: 10.1200/JCO.2009.21.8073. Epub 2009 Dec 14.

PMID:
20008642
8.

Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study.

Herbots L, D'hooge J, Eroglu E, Thijs D, Ganame J, Claus P, Dubois C, Theunissen K, Bogaert J, Dens J, Kalantzi M, Dymarkowski S, Bijnens B, Belmans A, Boogaerts M, Sutherland G, Van de Werf F, Rademakers F, Janssens S.

Eur Heart J. 2009 Mar;30(6):662-70. doi: 10.1093/eurheartj/ehn532. Epub 2008 Dec 23.

PMID:
19106196
9.

Effect of treatment with epoetin Beta on thromboembolic events in anemic patients with cancer: a metaanalysis.

Coiffier B, Boogaerts M, Aapro M, Hayward C, Burger HU.

Support Cancer Ther. 2006 Oct 1;4(1):49-55. doi: 10.3816/SCT.2006.n.031.

PMID:
18632466
10.

A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.

Russell N, Mesters R, Schubert J, Boogaerts M, Johnsen HE, Canizo CD, Baker N, Barker P, Skacel T, Schmitz N.

Haematologica. 2008 Mar;93(3):405-12. doi: 10.3324/haematol.11287. Epub 2008 Feb 11.

11.

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Sureda A, Robinson S, Canals C, Carella AM, Boogaerts MA, Caballero D, Hunter AE, Kanz L, Slavin S, Cornelissen JJ, Gramatzki M, Niederwieser D, Russell NH, Schmitz N.

J Clin Oncol. 2008 Jan 20;26(3):455-62. Epub 2007 Dec 17.

PMID:
18086796
12.

[Vascular access in hemodialysis].

Boogaerts M, Marjot M, Sainte-Croix F, Gadiou MF, Guillet C, Bonarek H.

Soins. 2007 Oct;(719 Suppl):S15. French. No abstract available.

PMID:
18050869
13.

The clinical significance of activated lymphocytes in patients with myelodysplastic syndromes: a single centre study of 131 patients.

Meers S, Vandenberghe P, Boogaerts M, Verhoef G, Delforge M.

Leuk Res. 2008 Jul;32(7):1026-35. Epub 2007 Nov 19.

PMID:
18006057
14.

Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40-CD40L interactions with T helper cells.

Meers S, Kasran A, Boon L, Lemmens J, Ravoet C, Boogaerts M, Verhoef G, Verfaillie C, Delforge M.

Leukemia. 2007 Dec;21(12):2411-9. Epub 2007 Sep 6.

PMID:
17805323
15.

A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Al-Ali HK, Brand R, van Biezen A, Finke J, Boogaerts M, Fauser AA, Egeler M, Cahn JY, Arnold R, Biersack H, Niederwieser D, de Witte T.

Leukemia. 2007 Sep;21(9):1945-51. Epub 2007 Jul 5.

PMID:
17611571
16.

A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification.

Verburgh E, Achten R, Louw VJ, Brusselmans C, Delforge M, Boogaerts M, Hagemeijer A, Vandenberghe P, Verhoef G.

Leukemia. 2007 Apr;21(4):668-77. Epub 2007 Feb 15.

PMID:
17301818
17.
18.

Antifungal prophylaxis in neutropenia.

Maertens JA, Boogaerts MA.

Curr Opin Infect Dis. 1999 Dec;12(6):549-55.

PMID:
17035820
19.

Adult umbilical cord blood transplantation: a comprehensive review.

Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C, Wagner J.

Bone Marrow Transplant. 2006 Jul;38(2):83-93. Epub 2006 Jun 5. Review.

PMID:
16751788
20.

Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.

Boogaerts M, Oberhoff C, Ten Bokkel Huinink W, Nowrousian MR, Hayward CR, Burger HU.

Anticancer Res. 2006 Jan-Feb;26(1B):479-84.

21.

Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant.

Lierman E, Folens C, Stover EH, Mentens N, Van Miegroet H, Scheers W, Boogaerts M, Vandenberghe P, Marynen P, Cools J.

Blood. 2006 Aug 15;108(4):1374-6. Epub 2006 Apr 27.

22.

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J, Bacigalupo A, Beelen D, Reiffers J, Devergie A, Alessandrino E, Mufti GJ, Barge R, Sierra J, Ruutu T, Boogaerts M, Falda M, Jouet JP, Niederwieser D, de Witte T; Myelodysplastic Syndrome subcommittee of the Chronic Leukemia Working Party of the European Blood and Marrow Transplantation Group.

Blood. 2006 Aug 1;108(3):836-46. Epub 2006 Apr 4.

23.

Bone marrow cell transfer in acute myocardial infarction.

Janssens S, Theunissen K, Boogaerts M, Van de Werf F.

Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S69-72.

PMID:
16501635
24.

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, Rademakers F, Dymarkowski S, Gheysens O, Van Cleemput J, Bormans G, Nuyts J, Belmans A, Mortelmans L, Boogaerts M, Van de Werf F.

Lancet. 2006 Jan 14;367(9505):113-21.

PMID:
16413875
25.

Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models.

Boogaerts M, Mittelman M, Vaupel P.

Oncology. 2005;69 Suppl 2:22-30. Epub 2005 Oct 21. Review.

PMID:
16244507
26.

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, Wilmer A, Verhaegen J, Boogaerts M, Van Eldere J.

Clin Infect Dis. 2005 Nov 1;41(9):1242-50. Epub 2005 Sep 29.

PMID:
16206097
27.

Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation.

Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C, Gluckman E, Bredius R, Boogaerts M, Vermylen C, Veys P, Marsh J, Badell I, Michel G, Güngör T, Niethammer D, Bordigoni P, Oswald C, Favre C, Passweg J, Dini G; EBMT Severe Aplastic Anaemia and Paediatric Diseases Working Party.

Br J Haematol. 2005 Oct;131(2):231-6. Erratum in: Br J Haematol. 2006 Jan;132(1):120. Breddius, Robbert [corrected to Bredius, Robbert].

PMID:
16197455
28.

The place for itraconazole in treatment.

Maertens J, Boogaerts M.

J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i33-i38. Review.

PMID:
16120632
29.

Unrecognized or potential risk factors for childhood cancer.

Van Larebeke NA, Birnbaum LS, Boogaerts MA, Bracke M, Davis DL, Demarini DM, Hooper K, Huff J, Kleinjans JC, Legator MS, Schoeters G, Vähäkangas K.

Int J Occup Environ Health. 2005 Apr-Jun;11(2):199-201.

PMID:
15875896
30.

A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias.

Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B, Van Roy N, Vandesompele J, Graux C, Uyttebroeck A, Boogaerts M, De Moerloose B, Benoit Y, Selleslag D, Billiet J, Robert A, Huguet F, Vandenberghe P, De Paepe A, Marynen P, Hagemeijer A.

Leukemia. 2005 Mar;19(3):358-66.

PMID:
15674412
31.

Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies.

de Greef GE, van Putten WL, Boogaerts M, Huijgens PC, Verdonck LF, Vellenga E, Theobald M, Jacky E, Löwenberg B; Dutch-Belgian Hemato-Oncology Co-operative Group HOVON; Swiss Group for Clinical Cancer Research SAKK.

Br J Haematol. 2005 Jan;128(2):184-91.

PMID:
15638852
32.

Prognostic index for adult patients with acute myeloid leukemia in first relapse.

Breems DA, Van Putten WL, Huijgens PC, Ossenkoppele GJ, Verhoef GE, Verdonck LF, Vellenga E, De Greef GE, Jacky E, Van der Lelie J, Boogaerts MA, Löwenberg B.

J Clin Oncol. 2005 Mar 20;23(9):1969-78. Epub 2005 Jan 4.

PMID:
15632409
33.
34.

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.

Dreyling M, Lenz G, Hoster E, Van Hoof A, Gisselbrecht C, Schmits R, Metzner B, Truemper L, Reiser M, Steinhauer H, Boiron JM, Boogaerts MA, Aldaoud A, Silingardi V, Kluin-Nelemans HC, Hasford J, Parwaresch R, Unterhalt M, Hiddemann W.

Blood. 2005 Apr 1;105(7):2677-84. Epub 2004 Dec 9.

35.

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, Sable CA, Kartsonis NA, Ngai A, Taylor A, Patterson TF, Denning DW, Walsh TJ; Caspofungin Salvage Aspergillosis Study Group.

Clin Infect Dis. 2004 Dec 1;39(11):1563-71. Epub 2004 Nov 9.

PMID:
15578352
36.

Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.

Offner F, Krcmery V, Boogaerts M, Doyen C, Engelhard D, Ribaud P, Cordonnier C, de Pauw B, Durrant S, Marie JP, Moreau P, Guiot H, Samonis G, Sylvester R, Herbrecht R; EORTC Invasive Fungal Infections Group.

Antimicrob Agents Chemother. 2004 Dec;48(12):4808-12.

37.

Clericuzio type poikiloderma with neutropenia is distinct from Rothmund-Thomson syndrome.

Van Hove JL, Jaeken J, Proesmans M, Boeck KD, Minner K, Matthijs G, Verbeken E, Demunter A, Boogaerts M.

Am J Med Genet A. 2005 Jan 15;132A(2):152-8.

PMID:
15558713
38.
39.

Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.

Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV.

Br J Haematol. 2004 Sep;126(6):852-60.

PMID:
15352990
40.

An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia.

Boeckx N, van der Velden VH, Boogaerts M, Hagemeijer A, Vandenberghe P, van Dongen JJ.

Haematologica. 2004 Aug;89(8):ECR28.

41.

Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes.

Ma L, Delforge M, van Duppen V, Verhoef G, Emanuel B, Boogaerts M, Hagemeijer A, Vandenberghe P.

Leukemia. 2004 Sep;18(9):1451-6.

PMID:
15284864
42.

Oral fludarabine therapy in chronic lymphocytic leukemia--increased convenience.

Boogaerts MA.

Hematol J. 2004;5 Suppl 1:S31-7. Review.

PMID:
15079151
43.

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients.

van der Velden VH, Boeckx N, Jedema I, te Marvelde JG, Hoogeveen PG, Boogaerts M, van Dongen JJ.

Leukemia. 2004 May;18(5):983-8.

PMID:
15029214
44.

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.

Vandenberghe P, Wlodarska I, Michaux L, Zachée P, Boogaerts M, Vanstraelen D, Herregods MC, Van Hoof A, Selleslag D, Roufosse F, Maerevoet M, Verhoef G, Cools J, Gilliland DG, Hagemeijer A, Marynen P.

Leukemia. 2004 Apr;18(4):734-42.

PMID:
14973504
45.

Clinical features suggestive of lymphadenopathy in a painting by Marinus Van Reymerswaele.

Dequeker J, Boogaerts M.

J R Coll Physicians Edinb. 2003;33(3):221-3. No abstract available.

PMID:
14738074
46.

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.

Cornelissen JJ, van der Holt B, Petersen EJ, Vindelov L, Russel CA, Höglund M, Maertens J, Schouten HC, Braakman E, Steijaert MM, Zijlmans MJ, Slaper-Cortenbach I, Boogaerts MA, Löwenberg B, Verdonck LF.

Exp Hematol. 2003 Oct;31(10):855-64.

PMID:
14550800
47.

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

Löwenberg B, van Putten W, Theobald M, Gmür J, Verdonck L, Sonneveld P, Fey M, Schouten H, de Greef G, Ferrant A, Kovacsovics T, Gratwohl A, Daenen S, Huijgens P, Boogaerts M; Dutch-Belgian Hemato-Oncology Cooperative Group; Swiss Group for Clinical Cancer Research.

N Engl J Med. 2003 Aug 21;349(8):743-52.

48.

Caspofungin in the treatment of candidosis and aspergillosis.

Maertens J, Boogaerts M.

Int J Infect Dis. 2003 Jun;7(2):94-101.

49.

Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes.

Delforge M, Raets V, Van Duppen V, Boogaerts M.

Leuk Res. 2003 Jul;27(7):593-8.

PMID:
12681358
50.

Impact of epoetin beta on quality of life in patients with malignant disease.

Boogaerts M, Coiffier B, Kainz C; Epoetin beta QOL Working Group.

Br J Cancer. 2003 Apr 7;88(7):988-95.

Supplemental Content

Loading ...
Support Center